U.S. MARKETS FOR HEART VALVE REPAIR AND REPLACEMENT PRODUCTS

183 Pages | 29 Exhibits | 2011 Analysis | Forecasts Through 2015 Product Family: Market Reports




OVERVIEW:
In the United States (U.S.), heart valve disorders are diagnosed in approximately 4 million people each year. Over the next half-decade, the total U.S. population will continue to expand, as will the percentage of the total population that is age 65 and older. The incidence of congenital heart disease and the steadily growing pool of older people living in the U.S. with age-related heart valve disorders will boost demand for heart valve repair/replacement procedures and products for the foreseeable future.

Together, heart valve repair/replacement procedures generated an estimated $754.3 million in corresponding product sales in the U.S. in 2010. It is expected that during the forecast period covered by this report, sales of heart valve repair/replacement products will increase at a compound annual rate of 18.2%, reaching an estimated $1,738.3 million in the year 2015.

This dynamic, new report from Medtech Insight includes analyses of products, current and forecast markets, competitors, and opportunities for suppliers of heart valve repair/replacement products to the U.S.

Covered topics in this report include an overview of heart valve disorders and heart valve repair/replacement technologies; annuloplasty rings, bands, and accessories; autograft and homograft heart valves; bovine, equine, and porcine heterograft heart valves; emerging/existing transcatheter heart valve repair and replacement products; mechanical heart valve replacement products and procedures; percutaneous balloon valvuloplasty products; pharmaceutical products used in the treatment of patients with cardiovascular disorders; surgical and transcatheter heart valve repair/replacement procedures and products; tissue engineering related to the development of autologous heart valves; and tissue heart valve replacement products and procedures.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Heart Valve Repair Systems Market 
ii. Heart Valve Replacement Systems Market 
	a. Mechanical Heart Valve Replacement Systems 
	b. Tissue Heart Valve Replacement Systems 

Exhibit ES-1: Heart Valve Repair/Replacement, Combined Procedure Volumes Forecast, 2010-2015 
Exhibit ES-2: Heart Valve Repair/Replacement Products, Combined Market Forecast, 2010-2015 
Exhibit ES-3: Heart Valve Repair, Procedure Volumes Forecast, 2010-2015 
Exhibit ES-4: Heart Valve Repair Systems, Market Forecast, 2010-2015 
Exhibit ES-5: Heart Valve Replacement, Procedure Volumes Forecast, 2010-2015 
Exhibit ES-6: Heart Valve Replacement Systems, Market Forecast, 2010-2015 
Exhibit ES-7: Mechanical Heart Valve Replacement, Procedure Volumes Forecast, 2010-2015 
Exhibit ES-8: Mechanical Heart Valve Replacement Systems,  Market Forecast, 2010-2015 
Exhibit ES-9: Tissue Heart Valve Replacement, Procedure Volumes Forecast, 2010-2015 
Exhibit ES-10: Tissue Heart Valve Replacement Systems,  Market Forecast, 2010-2015 

1. OVERVIEW OF HEART VALVE DISORDERS AND REPAIR/REPLACEMENT PROCEDURES

1.1 Heart Anatomy and Physiology 
	1.1.1 The Cardiac Conduction System 
	1.1.2 The Heart Valves 
		1.1.2.1 Atrioventricular Valves 
			1.1.2.1.1 Tricuspid Valve 
			1.1.2.1.2 Mitral Valve 
		1.1.2.2 Semilunar Valves 
			1.1.2.2.1 Aortic Valve 
			1.1.2.2.2 Pulmonary Valve 
1.2 Heart Valve Disorders 
	1.2.1 Types of Heart Valve Disorders 
		1.2.1.1 Valvular Stenosis 
			1.2.1.1.1 Aortic Valve/Mitral Valve Stenosis 
			1.2.1.1.2 Tricuspid Valve/Pulmonary Valve Stenosis 
		1.2.1.2 Valvular Regurgitation 
			1.2.1.2.1 Aortic Valve/Mitral Valve Regurgitation 
			1.2.1.2.2 Tricuspid Valve/Pulmonary Valve Regurgitation 
			1.2.1.2.3 Valve Prolapse 
	1.2.2 Conditions Associated with Heart Valve Disorders 
		1.2.2.1 Congenital Defects 
			1.2.2.1.1 Ebstein's Anomaly 
			1.2.2.1.2 Marfan Syndrome 
			1.2.2.1.3 Pulmonary Atresia 
			1.2.2.1.4 Tetralogy of Fallot 
			1.2.2.1.5 Tricuspid Atresia 
		1.2.2.2 Acquired Disorders 
			1.2.2.2.1 Calcific Degeneration 
			1.2.2.2.2 Infective Endocarditis 
				1.2.2.2.2.1 Acute Infective Endocarditis 
				1.2.2.2.2.2 Subacute Infective Endocarditis 
			1.2.2.2.3 Libman-Sacks Endocarditis 
			1.2.2.2.4 Myxomatous Degeneration 
			1.2.2.2.5 Rheumatic Fever 
1.3 Heart Valve Disorder Treatment Strategies 
	1.3.1 Pharmaceutical Regimens 
		1.3.1.1 Anticoagulants and Antiplatelet Drugs 
		1.3.1.2 Antiarrhythmics 
		1.3.1.3 Diuretics 
		1.3.1.4 Vasodilators 
		1.3.1.5 Statins 
	1.3.2 Surgical/Interventional Solutions 
		1.3.2.1 Techniques 
			1.3.2.1.1 Open-Heart Surgery 
			1.3.2.1.2 Minimally Invasive Techniques 
			1.3.2.1.3 Interventional Methods 
		1.3.2.2 Heart Valve Repair 
			1.3.2.2.1 Annuloplasty 
			1.3.2.2.2 Percutaneous Balloon Valvuloplasty 
			1.3.2.2.3 Transcatheter Mitral Valve Repair Techniques 
		1.3.2.3 Heart Valve Replacement 
			1.3.2.3.1 Types of Replacement Valves 
				1.3.2.3.1.1 Mechanical Heart Valves 
				1.3.2.3.1.2 Tissue Heart Valves 
		1.3.2.4 Procedure Volumes 

Exhibit 1-1: Cross-Section Diagram of the Normal Heart 
Exhibit 1-2: Cross-Section Diagram of the Heart Valves 
Exhibit 1-3: Characteristics of the Ideal Prosthetic Heart Valve 
Exhibit 1-4: Heart Valve Repair, Procedure Volumes Forecast, 2010-2015 
Exhibit 1-5: Heart Valve Replacement, Procedure Volumes Forecast, 2010-2015 
Exhibit 1-6: Surgical and Transcatheter Heart Valve Repair/Replacement, Procedure Volumes Forecast, 2010-2015 
Exhibit 1-7: Heart Valve Repair/Replacement, Combined Procedure Volumes Forecast, 2010-2015 

2. MECHANICAL HEART VALVE REPLACEMENT SYSTEMS MARKET

2.1 Mechanical Heart Valve Replacement Systems, Development/Design 
2.2 Mechanical Heart Valve Replacement Systems, Market Analysis 
	2.2.1 Products 
	2.2.2 Procedure Volumes 
	2.2.3 Market Forecast 
	2.2.4 Competitive Analysis 
		2.2.4.1 St. Jude Medical 
		2.2.4.2 Sorin Group 
		2.2.4.3 ATS Medical 
		2.2.4.4 On-X Life Technologies 

Exhibit 2-1: 2011, Selected Mechanical Heart Valve Replacement Systems 
Exhibit 2-2: Mechanical Heart Valve Replacement, Procedure Volumes Forecast, 2010-2015 
Exhibit 2-3: Mechanical Heart Valve Replacement Systems,  Market Forecast, 2010-2015 
Exhibit 2-4: 2010, Mechanical Heart Valve Replacement Systems Market, Share by Supplier 

3. TISSUE HEART VALVE REPLACEMENT SYSTEMS MARKET

3.1 Tissue Heart Valve Replacement Systems, Development/Design 
	3.1.1 Autograft, Homograft, and Heterograft Valves 
	3.1.2 Stented versus Stentless Valves 
	3.1.3 Tissue-Engineered Valves 
3.2 Tissue Heart Valve Replacement Systems, Market Analysis 
	3.2.1 Products 
	3.2.2 Procedure Volumes 
	3.2.3 Market Forecast 
	3.2.4 Competitive Analysis 
		3.2.4.1 Surgical Tissue Heart Valve Suppliers 
			3.2.4.1.1 Edwards Lifesciences 
			3.2.4.1.2 Medtronic 
			3.2.4.1.3 St. Jude Medical 
			3.2.4.1.4 CryoLife 
			3.2.4.1.5 Sorin Group 
			3.2.4.1.6 ATS Medical 
		3.2.4.2 Transcatheter Tissue Heart Valve Developers 
			3.2.4.2.1 Direct Flow Medical 
			3.2.4.2.2 Edwards Lifesciences 
			3.2.4.2.3 Hansen Medical 
			3.2.4.2.4 JenaValve Technology 
			3.2.4.2.5 Medtronic 
			3.2.4.2.6 Sadra Medical 
			3.2.4.2.7 ValveXchange 

Exhibit 3-1: 2011, Selected Tissue Heart Valve Replacement Systems 
Exhibit 3-2: Tissue Heart Valve Replacement, Procedure Volumes Forecast, 2010-2015 
Exhibit 3-3: Tissue Heart Valve Replacement Systems,  Market Forecast, 2010-2015 
Exhibit 3-4: 2010, Tissue Heart Valve Replacement Systems Market,  Share by Supplier 

4. HEART VALVE REPAIR SYSTEMS MARKET

4.1 Heart Valve Repair Systems, Development/Design 
4.2 Heart Valve Repair Systems, Market Analysis 
	4.2.1 Products 
	4.2.2 Procedure Volumes 
	4.2.3 Market Forecast 
	4.2.4 Competitors 
		4.2.4.1 Surgical Heart Valve Repair Device Suppliers 
			4.2.4.1.1 Edwards LIfesciences 
			4.2.4.1.2 Medtronic 
			4.2.4.1.3 St. Jude Medical 
			4.2.4.1.4 Sorin Group 
			4.2.4.1.5 ATS Medical/Medtronic 
		4.2.4.2 Percutaneous Balloon Valvuloplasty Device Suppliers 
			4.2.4.2.1 NuMED 
			4.2.4.2.2 Toray Industries/Toray Group 
		4.2.4.3 Transcatheter Heart Valve Repair Device Developers 
			4.2.4.3.1 Abbott Vascular/Abbott Laboratories 
			4.2.4.3.2 Cardiac Dimensions 
			4.2.4.3.3 MiCardia 
			4.2.4.3.4 Mitralign 

Exhibit 4-1: 2011, Selected Heart Valve Repair Systems 
Exhibit 4-2: Heart Valve Repair, Procedure Volumes Forecast, 2010-2015 
Exhibit 4-3: Heart Valve Repair Systems, Market Forecast, 2010-2015 
Exhibit 4-4: 2010, Heart Valve Repair Systems Market, Share by Supplier 

5. COMPANY PROFILES

5.1 Abbott Vascular/Abbott Laboratories 
5.2 ATS Medical/Medtronic, Inc. 
5.3 Cardiac Dimensions, Inc. 
5.4 CryoLife, Inc. 
5.5 Edwards Lifesciences Corporation 
5.6 Medtronic, Inc. 
5.7 MiCardia Corporation 
5.8 NuMED, Inc. 
5.9 On-X Life Technologies, Inc. 
5.10 Sorin Group SpA 
5.11 St. Jude Medical, Inc. 
5.12 Toray International America, Inc./Toray International, Inc./Toray Group 
5.13 ValveXchange, Inc. 

APPENDIX:  COMPANY LISTING


COMPANIES COVERED:

  1. Abbott Vascular/Abbott Laboratories
  2. ATS Medical/Medtronic, Inc.
  3. Cardiac Dimensions, Inc.
  4. CryoLife, Inc.
  5. Edwards Lifesciences Corporation
  6. Medtronic, Inc.
  7. MiCardia Corporation
  8. NuMED, Inc.
  9. On-X Life Technologies, Inc.
  10. Sorin Group SpA
  11. St. Jude Medical, Inc.
  12. Toray International America, Inc./Toray International, Inc./Toray Group
  13. ValveXchange, Inc.
Contact Us

Need help finding medtech research? Let us help you!